Lisa Kottschade

7PUBLICATIONS
76CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Molecular targetsMedical virologyApplications in health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 30, 2024
Identification and Characterization of Immune Checkpoint Inhibitor-Induced Toxicities From Electronic Health Records Using Natural Language Processing.

Hannah Barman, Sriram Venkateswaran, Antonio Del Santo

|Mar 26, 2024
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies.

Eleftheria Kalogera, Wendy K Nevala, Heidi D Finnes

|Jan 04, 2024
Defining the Role of the Advanced Practice Provider Within the National Cancer Institute Community Oncology Research Program.

Christa M Braun-Inglis, Emily V Dressler, Jamie S Myers

|Oct 26, 2023
Plasma Methylated DNA Markers for Melanoma Surveillance.

Calise K Berger, William R Taylor, Douglas W Mahoney

|Mar 31, 2023
SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma.

Lisa A Kottschade, Gregory Russell Pond, Anthony J Olszanski

Pageof 2